A comparison of chaffhaye and alfalfa hay on digestibility and glucose metabolism in mature, stock-type horses

被引：0
|
作者：
Hansen, A. [1 ]
Oates, A. [1 ]
Gaskins, D. [1 ]
Loest, C. [1 ]
White, L. [1 ]
机构：
[1] New Mexico State Univ, Las Cruces, NM 88003 USA
来源：
JOURNAL OF ANIMAL SCIENCE | 2018年 / 96卷
关键词：
Horse; Digestibility; Haylage;
D O I：
暂无
中图分类号：
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号：
0905 ;
摘要：
466
引用
收藏
页码：248 / 249
页数：2
相关论文
共 50 条
  • [41] Comparison of lymphomononuclear cell energy metabolism between healthy, impaired glucose intolerance and type 2 diabetes mellitus patients (vol 37, pg 135, 2010)
    Ozsari, L.
    Boyunaga, H.
    Karadurmus, N.
    Sahin, M.
    Uckaya, G.
    Ural, A. U.
    Kenar, L.
    Kutlu, M.
    ENDOCRINE, 2010, 38 (01) : 142 - 142
  • [42] Comparison between glimepiride plus pioglitazone vs. glimepiride plus rosiglitazone on glucose metabolism and on lipid, lipoprotein and apolipoprotein fractions in type 2 diabetic patients
    Derosa, G
    Mugellini, A
    Ragonesi, P
    Ciccarelli, L
    Boschi, D
    Ghelfi, M
    Fogari, R
    DIABETES, 2003, 52 : A458 - A459
  • [43] Comparison between repaglinide plus metformin vs glimepiride plus metformin on glucose metabolism and lipoprotein (a) in type 2 diabetic patients: A 1-year study
    Ciccarelli, L
    Derosa, G
    Mugellini, A
    Boschi, D
    Ghelfi, M
    Fogari, R
    DIABETES, 2003, 52 : A458 - A458
  • [44] Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon-like peptide-1/glucagon receptor agonist SAR425899 in comparison with liraglutide
    Schiavon, Michele
    Visentin, Roberto
    Gobel, Britta
    Riz, Michela
    Cobelli, Claudio
    Klabunde, Thomas
    Dalla Man, Chiara
    DIABETES OBESITY & METABOLISM, 2021, 23 (08): : 1795 - 1805
  • [45] COMPARISON OF WILD-TYPE AND REG1 MUTANT-SACCHAROMYCES-CEREVISIAE METABOLIC LEVELS DURING GLUCOSE AND GALACTOSE METABOLISM USING 31P NMR
    SHANKS, JV
    BAILEY, JE
    BIOTECHNOLOGY AND BIOENGINEERING, 1990, 35 (04) : 395 - 407
  • [46] Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism
    Cindy Casteels
    Emili Martinez
    Guy Bormans
    Lluïsa Camon
    Núria de Vera
    Veerle Baekelandt
    Anna M. Planas
    Koen Van Laere
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 2354 - 2363
  • [47] Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism
    Casteels, Cindy
    Martinez, Emili
    Bormans, Guy
    Camon, Lluisa
    de Vera, Nuria
    Baekelandt, Veerle
    Planas, Anna M.
    Van Laere, Koen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (12) : 2354 - 2363
  • [48] Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: A 12-month, randomized, double-blind study
    Derosa, G
    Cicero, AFG
    Bertone, G
    Piccinni, MN
    Fogari, E
    Ciccarelli, L
    Fogari, R
    CLINICAL THERAPEUTICS, 2004, 26 (08) : 1228 - 1236
  • [49] Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study)
    Nomoto, Hiroshi
    Furusawa, Sho
    Nakamura, Akinobu
    Takeuchi, Jun
    Nagai, So
    Yokoyama, Hiroki
    Sakuma, Ichiro
    Taneda, Shinji
    Kurihara, Yoshio
    Aoki, Shin
    Miya, Aika
    Kameda, Hiraku
    Cho, Kyu Yong
    Atsumi, Tatsuya
    Miyoshi, Hideaki
    BMJ OPEN, 2022, 12 (05):
  • [50] Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus: An open-label, prospective, randomized, parallel-group comparison trial
    Cho, Kyu Yong
    Nakamura, Akinobu
    Omori, Kazuno
    Takase, Takahiro
    Miya, Aika
    Manda, Naoki
    Kurihara, Yoshio
    Aoki, Shin
    Atsumi, Tatsuya
    Miyoshi, Hideaki
    DIABETES OBESITY & METABOLISM, 2019, 21 (03): : 710 - 714
12345